Export Sales Growth Consulting Services for Indian Drugs & Pharmaceuticals | ZJELL

APIs • Finished Dosage Forms • Vaccines & Biologics • OTC • Pharma Goods

Win more export orders for APIs, FDFs, vaccines & OTC from India. ZJELL delivers buyer access, registrations, tenders, compliant logistics & trade finance. ZJELL is a deal-focused export consultant partner for Indian pharmaceutical manufacturers. We convert your pipeline—APIs, formulations, vaccines/biologics and OTC—into qualified opportunities, tenders and purchase orders, with airtight regulatory compliance, GDP logistics and secure payments across the US/EU/UK, Africa, LATAM, CIS and ASEAN/GCC.

What we grow (categories + HS focus)

We map every SKU to HS codes for clean classification, pricing and market selection.

APIs / Bulk Drugs — HS 29 (e.g., 2933 heterocyclics, 2934 nucleic acids, 2935 sulfonamides, 2941 antibiotics, 2942 other organic compounds)
Finished Dosage Forms (FDFs) — HS 3003/3004 (medicaments; non-dosed vs dosed/retail)
Vaccines, Sera, Biologics & Cultures — HS 3002
Pharmaceutical Goods & Kits — HS 3006 (diagnostic reagents, gel preparations, first-aid boxes)
Dressings & Bandages — HS 3005
(Devices are typically HS 90 and handled via a separate MedTech desk.)

Buyer segments we target: government MoH & tender bodies, multilaterals (UN/UNICEF/PAHO/Global Fund), large importers/distributors, hospital chains, pharmacy groups, and private-label programs.

Export Sales Growth for Indian Drugs & Pharmaceuticals | ZJELL

The ZJELL Export-Growth Stack (end-to-end)

Market selection (HS-led): import growth, IP/exclusivity landscape, tariffs/FTA, dossier pathways, buyer density.
Regulatory pathway & registration plan: CTD/eCTD gap analysis, CPP/CoPP & WHO-GMP alignment; country files for GCC, ASEAN, Africa, LATAM, CIS; US/EU plans when applicable.
Channel & tender development: distributor audits, exclusivity terms, performance KPIs, tender calendars, bid packs.
Demand generation: compliant outreach to qualified buyers, expo meeting sets, RFQ desk.
Quote/Tender desk: multi-currency offers, INCO terms, shelf-life & stability windows, pharmacovigilance commitments, win–loss hygiene.
Quality & documentation: CoA, BMR/BPR extracts, SMF & Site GMP, stability/ICH, MSDS, PV system master file, artwork control.
Cold-chain & GDP logistics: 2–8 °C lanes, data-logged shippers, route risk, insurance & claims prevention.
Trade finance: LCs, DP/DA risk control, credit checks, BGs & insurer coordination.
CRM & automation: Zoho pipelines, regulatory trackers, document vaults, renewal alerts.
Governance: weekly deal reviews, forecast accuracy, DSO, OTIF-C (on-temp/on-time/in-full).

90-Day Export Sprint (typical)

Weeks 0–2 | Discover & Decide
SKU & dossier audit, HS mapping, Top-5 markets rank, 150–300 target accounts/tenders.
Weeks 3–4 | Build & Enable
Registration roadmap, buyer deck, price book (EXW/FOB/CIF), PV & QA statement set, CRM launch.
Weeks 5–8 | Pipeline & RFQs
Buyer outreach, distributor evaluations, tender prep, samples & stability commitments, GMP/QMS Q&A.
Weeks 9–12 | Close & Ship
Commercials & LC scrutiny, artwork/label approvals, lane booking (ambient/cold), export docs pack, first PO(s) in motion.

Baseline KPIs: qualified opps, tender submissions, approval/registration milestones, cycle time, DSO, OTIF-C.

Documentation pack we prepare

CPP/CoPP, WHO-GMP, CoA & specs, stability summaries, DMF/ASMF status (where relevant), SMF/QMS statements, PV agreements, MSDS, labels/IFU, Registration forms (country-specific), Commercial & Proforma Invoices, COO, Packing List, Health/Phytosanitary (if required), Insurance, LC compliance notes.

Export Sales Growth Services for Indian Drugs & Pharmaceuticals | ZJELL

Compliance statement

B2B only. We serve licensed manufacturers/holders of the required approvals.
No narcotics/psychotropics or controlled substances without applicable licenses and permits.
All marketing and communications remain regulation-compliant and non-promotional to consumers.

Why Indian pharma chooses ZJELL

Deal-makers, not just advisors — we own pipeline targets and sit on your forecast calls.
Regulatory-first execution — fewer border holds and faster cash cycles.
Cold-chain know-how — validated packaging and lower claim rates.
Automation built-in — renewal & stability trackers that prevent lapses.

Engagement options

Sprint GTM (90 days): fast entry, first POs/tenders.
Managed Export Desk (6–12 months): retainer + success fee; registrations through to shipments.
Tender & Registration Programs: dossier build, submission, renewals, and bid management.

FAQs

1. Which markets should we start with?
We score import growth, registration complexity, tariffs/FTA, lane cost, buyer density and competitive intensity—then shortlist 3–5.

2. Can you help with dossier and PV?
Yes—CTD/eCTD gap map, CPP/WHO-GMP collation, PV agreements, artwork & labelling, stability/IQ-OQ-PQ evidence where needed.

3. Do you support cold-chain shipments?
We design GDP-compliant lanes (2–8 °C/-20 °C), choose validated shippers & loggers, and manage insurance/claim prevention.

4. How do you de-risk LCs?
Pre-check LC terms, prepare a document calendar, and build a claims-prevention checklist (temps, seals, photos, SGS/Intertek).